Quality of Sexual Function in BRCA Mutated Women
Launched by AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA · Jul 10, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the quality of sexual function in women who have a BRCA mutation, which is a genetic change that can increase the risk of certain cancers. Researchers want to understand how this mutation affects sexual health and well-being by using a questionnaire called the SFQ28. The trial is currently recruiting female participants aged between 36 and 74 who have been diagnosed with a BRCA mutation.
If you decide to participate, you will complete the questionnaire, which will help researchers gather information about your sexual function and any related issues you may be facing. This study aims to better understand the experiences of women with BRCA mutations, which could lead to improved support and treatment options. It's important to note that specific eligibility criteria are still being determined, so please check with the study team for more details on who can join.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • TBC
- Exclusion Criteria:
- • TBC
About Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
The Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia is a leading healthcare organization based in Brescia, Italy, dedicated to providing high-quality medical services and promoting clinical research. As a prominent clinical trial sponsor, it focuses on advancing medical knowledge and improving patient care through innovative research initiatives. The institution integrates multidisciplinary expertise and state-of-the-art facilities to facilitate the development of new therapies and treatments, ensuring adherence to rigorous ethical and regulatory standards. With a commitment to enhancing public health, the Azienda plays a pivotal role in fostering collaborations among healthcare professionals, researchers, and industry partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brescia, Bs, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials